| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | +45.6% |
| Cost of Revenue | $3.8M | +53.8% |
| Gross Profit | $1.4M | +27.4% |
| R&D Expense | $1.4M | -3.3% |
| SG&A Expense | $6.7M | +8.8% |
| Operating Income | -$6.7M | -2.8% |
| Pre-tax Income | -$5.5M | -2.9% |
| Income Tax | $0 | — |
| Net Income | -$5.5M | -3.7% |
| EPS (Basic) | -$0.99 | -800.0% |
| EPS (Diluted) | -$0.99 | -800.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -34.6% |
| Accounts Receivable | $1.4M | +724.2% |
| Current Assets | $11.2M | -24.4% |
| Total Assets | $12.2M | -23.5% |
| Current Liabilities | $2.6M | +26.7% |
| Total Liabilities | $2.7M | +23.2% |
| Stockholders' Equity | $9.5M | -30.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | -8.3% |
| Capital Expenditures | $4K | -89.7% |
| Investing Cash Flow | -$101K | +53.7% |
| Financing Cash Flow | -$21K | -100.2% |
| Free Cash Flow | -$4.7M | -7.4% |